South African consortium establishes mRNA tech transfer hub to get vaccines to a region often overlooked
The WHO and COVAX on Monday announced the support of a South African consortium to establish a Covid-19 mRNA vaccine technology transfer hub. Over the next few weeks, partners from Biovac, Afrigen Biologics and Vaccines, the African CDC and a network of universities will negotiate details with the South African government to establish ground rules.
A technology transfer hub will allow manufacturers to receive training in vaccine technology and learn about the intellectual property of large drugmakers. The news is key for the continent, advocates say, because of its lack of widespread access to vaccines.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.